ASTROTECH Corp OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax
ASTROTECH Corp (ASTC) reported OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax of -$524.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax · last filed 2022-05-13
- ASTROTECH Corp oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2022-03-31 was -$524.00K.
- ASTROTECH Corp oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2021-12-31 was -$197.00K.
- ASTROTECH Corp oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2021-09-30 was -$48.00K.
- ASTROTECH Corp oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2018-09-30 was $31.00K, a 1450.00% increase year-over-year.
- ASTROTECH Corp oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for fiscal 2021 was -$23.00K.
- ASTROTECH Corp oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for fiscal 2019 was $31.00K, a 3.33% increase from fiscal 2018.
- ASTROTECH Corp oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for fiscal 2018 was $30.00K, a 25.00% decline from fiscal 2017.
- ASTROTECH Corp oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for fiscal 2017 was $40.00K.
| Period end | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 3 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 6 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 9 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$524.00K 10-Q · filed 2022-05-13 | -$721.00K derived: sum of 2 quarters · filed 2022-05-13 | -$769.00K derived: sum of 3 quarters · filed 2022-05-13 | |
| 2021-12-31 | -$197.00K 10-Q · filed 2022-05-13 | -$245.00K derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2021-09-30 | -$48.00K 10-Q · filed 2022-05-13 | |||
| 2021-06-30 | -$23.00K 10-K · filed 2021-09-21 | |||
| 2019-06-30 | $31.00K 10-K · filed 2020-09-08 | |||
| 2018-09-30 | $31.00K 10-Q · filed 2020-05-14 | |||
| 2018-06-30 | $30.00K 10-K · filed 2019-09-30 | |||
| 2018-03-31 | $10.00K 10-Q · filed 2019-05-13 | $7.00K derived: sum of 2 quarters · filed 2019-05-13 | $9.00K derived: sum of 3 quarters · filed 2019-05-13 | |
| 2017-12-31 | -$3.00K 10-Q · filed 2019-05-13 | -$1.00K derived: sum of 2 quarters · filed 2019-05-13 | ||
| 2017-09-30 | $2.00K 10-Q · filed 2019-05-13 | |||
| 2017-06-30 | $40.00K 10-K · filed 2018-09-25 | |||
| 2016-06-30 | -$78.00K 10-K · filed 2017-09-18 | |||
| 2015-06-30 | -$23.00K 10-K · filed 2016-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |